• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乙肝表面抗原携带者血清中定量乙肝表面抗原和乙肝病毒DNA水平的变化:一项老年队列的随访研究

Changing serum levels of quantitative hepatitis B surface antigen and hepatitis B virus DNA in hepatitis B virus surface antigen carriers: a follow-up study of an elderly cohort.

作者信息

Kuo Yuan-Hung, Chang Kuo-Ching, Wang Jing-Houng, Tsai Pei-Shan, Hung Shu-Feng, Hung Chao-Hung, Lu Sheng-Nan

机构信息

Division of Hepato-Gastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.

Health Center of Zihguan Township, Kaohsiung, Taiwan.

出版信息

Kaohsiung J Med Sci. 2015 Feb;31(2):102-7. doi: 10.1016/j.kjms.2014.11.002. Epub 2014 Dec 4.

DOI:10.1016/j.kjms.2014.11.002
PMID:25645989
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11916649/
Abstract

This study was to elucidate longitudinally quantitative changes of hepatitis B virus (HBV) surface antigen (HBsAg) and HBV DNA in elder HBsAg carriers in a community. Among 1002 residents screened for HBsAg in 2005, 405 responded to this follow-up study in 2010. Fifty-nine (14.6%) were HBsAg carriers in 2005; HBsAg quantification and HBV DNA were measured. HBsAg quantification (cutoff 1600 IU/mL) and HBV DNA (cutoff 2000 IU/mL) were combined to stratify the participants between two screens. A total of 30 men and 29 women with a mean age of 63.9 ± 7.9 years were enrolled. Quantitative levels of HBsAg and HBV DNA were significantly correlated in 2005 (r = 0.509, p < 0.001) and 2010 (r = 0.777, p < 0.001). Concentrations of HBsAg (IU/mL) significantly decreased from 2.2 ± 1.0 log in 2005 to 1.7 ± 1.5 log in 2010 (p < 0.001). The level of HBsAg was decreased in 48 (81.4%) individuals and HBsAg was undetectable in eight (13.6%). The annual incidence of HBsAg clearance was 2.7%. These 59 HBsAg carriers in 2005 were divided into four groups: low HBsAg low HBV DNA (n = 32), high HBsAg low HBV DNA (n = 5), low HBsAg high HBV DNA (n = 12) and high HBsAg high HBV DNA (n = 10). All 32 individuals in the low HBsAg low HBV DNA group were still in that group in 2010, whereas only two of the high HBsAg high HBV DNA group became inactive. As with a younger cohort in hospital, HBsAg quantification was still well correlated with HBV DNA in elderly HBsAg carriers in the community. Lower levels of both HBsAg and HBV DNA might represent an inactive HBV infection.

摘要

本研究旨在纵向阐明社区中老年乙肝表面抗原(HBsAg)携带者体内乙肝病毒(HBV)表面抗原及HBV DNA的定量变化。在2005年筛查HBsAg的1002名居民中,405人在2010年参与了这项随访研究。2005年时,59人(14.6%)为HBsAg携带者;对其进行了HBsAg定量检测及HBV DNA检测。结合HBsAg定量检测(临界值1600 IU/mL)及HBV DNA检测(临界值2000 IU/mL)结果,将两次筛查之间的参与者进行分层。共纳入30名男性和29名女性,平均年龄为63.9±7.9岁。2005年及2010年时,HBsAg定量水平与HBV DNA均显著相关(2005年:r = 0.509,p < 0.001;2010年:r = 0.777,p < 0.001)。HBsAg浓度(IU/mL)从2005年的2.2±1.0 log显著降至2010年的1.7±1.5 log(p < 0.001)。48人(81.4%)的HBsAg水平下降,8人(13.6%)检测不到HBsAg。HBsAg清除的年发生率为2.7%。2005年的这59名HBsAg携带者被分为四组:低HBsAg低HBV DNA组(n = 32)、高HBsAg低HBV DNA组(n = 5)、低HBsAg高HBV DNA组(n = 12)和高HBsAg高HBV DNA组(n = 10)。低HBsAg低HBV DNA组的所有32人在2010年仍处于该组,而高HBsAg高HBV DNA组只有两人转为非活动性感染。与医院中的年轻队列一样,社区中老年HBsAg携带者中HBsAg定量与HBV DNA仍密切相关。较低水平的HBsAg和HBV DNA可能代表HBV感染呈非活动性。

相似文献

1
Changing serum levels of quantitative hepatitis B surface antigen and hepatitis B virus DNA in hepatitis B virus surface antigen carriers: a follow-up study of an elderly cohort.乙肝表面抗原携带者血清中定量乙肝表面抗原和乙肝病毒DNA水平的变化:一项老年队列的随访研究
Kaohsiung J Med Sci. 2015 Feb;31(2):102-7. doi: 10.1016/j.kjms.2014.11.002. Epub 2014 Dec 4.
2
Role of hepatitis B surface antigen (HBsAg) in identifying true inactive HBsAg carriers infected with genotype C hepatitis B virus.乙型肝炎表面抗原(HBsAg)在鉴定感染 C 基因型乙型肝炎病毒的真正无活动 HBsAg 携带者中的作用。
J Clin Gastroenterol. 2014 Feb;48(2):166-71. doi: 10.1097/MCG.0b013e3182a4711d.
3
Long-term outcome of inactive and active, low viraemic HBeAg-negative-hepatitis B virus infection: Benign course towards HBsAg clearance.HBeAg 阴性慢性乙型肝炎病毒感染者的非活动和低病毒血症状态的长期结局:向 HBsAg 清除的良性过程。
Liver Int. 2017 Nov;37(11):1622-1631. doi: 10.1111/liv.13416. Epub 2017 Apr 18.
4
Repeated Measurements of Hepatitis B Surface Antigen Identify Carriers of Inactive HBV During Long-term Follow-up.多次检测乙肝表面抗原可在长期随访中识别出非活动期 HBV 携带者。
Clin Gastroenterol Hepatol. 2016 Oct;14(10):1481-1489.e5. doi: 10.1016/j.cgh.2016.01.019. Epub 2016 Feb 10.
5
Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers.乙型肝炎表面抗原血清水平有助于区分活跃和不活跃的乙型肝炎病毒基因型 D 携带者。
Gastroenterology. 2010 Aug;139(2):483-90. doi: 10.1053/j.gastro.2010.04.052. Epub 2010 May 5.
6
Predictive value of HBsAg quantification for determining the clinical course of genotype C HBeAg-negative carriers.HBsAg 定量对预测基因型 C HBeAg 阴性携带者的临床病程的价值。
Liver Int. 2012 May;32(5):796-802. doi: 10.1111/j.1478-3231.2011.02693.x. Epub 2011 Nov 30.
7
Role of quantitative hepatitis B surface antigen in predicting inactive carriers and HBsAg seroclearance in HBeAg-negative chronic hepatitis B patients.定量乙肝表面抗原在预测HBeAg阴性慢性乙型肝炎患者非活动性携带者及HBsAg血清学清除中的作用
Medicine (Baltimore). 2017 Mar;96(13):e6554. doi: 10.1097/MD.0000000000006554.
8
Prediction of disease reactivation in asymptomatic hepatitis B e antigen-negative chronic hepatitis B patients using baseline serum measurements of HBsAg and HBV-DNA.使用 HBsAg 和 HBV-DNA 的基线血清学测量预测无症状乙型肝炎 e 抗原阴性慢性乙型肝炎患者的疾病再激活。
J Clin Virol. 2013 Oct;58(2):401-7. doi: 10.1016/j.jcv.2013.08.010. Epub 2013 Aug 16.
9
Serum Levels of Hepatitis B Surface Antigen and DNA Can Predict Inactive Carriers With Low Risk of Disease Progression.血清乙型肝炎表面抗原和 DNA 水平可预测疾病进展风险低的非活动携带者。
Hepatology. 2016 Aug;64(2):381-9. doi: 10.1002/hep.28552. Epub 2016 Apr 15.
10
Serum hepatitis B core-related antigen is more accurate than hepatitis B surface antigen to identify inactive carriers, regardless of hepatitis B virus genotype.血清乙型肝炎核心相关抗原比乙型肝炎表面抗原更能准确识别非活动携带者,而与乙型肝炎病毒基因型无关。
Clin Microbiol Infect. 2017 Nov;23(11):860-867. doi: 10.1016/j.cmi.2017.03.003. Epub 2017 Mar 11.

引用本文的文献

1
Interim Analysis of 48-week Tenofovir Amibufenamide Treatment in Chronic Hepatitis B Patients with Normal Alanine Aminotransferase Levels: The PROMOTE Study.替诺福韦阿米布芬胺治疗丙氨酸氨基转移酶水平正常的慢性乙型肝炎患者48周的中期分析:PROMOTE研究
J Clin Transl Hepatol. 2025 Jul 28;13(7):568-577. doi: 10.14218/JCTH.2025.00162. Epub 2025 Jun 30.
2
Hepatitis B virus (HBV) viral load, liver and renal function in adults treated with tenofovir disoproxil fumarate (TDF) vs. untreated: a retrospective longitudinal UK cohort study.乙肝病毒 (HBV) 病毒载量、肝肾功能在接受富马酸替诺福韦二吡呋酯 (TDF) 治疗与未治疗的成年人中的变化:一项回顾性纵向英国队列研究。
BMC Infect Dis. 2021 Jun 26;21(1):610. doi: 10.1186/s12879-021-06226-0.
3
Estimating the proportion of people with chronic hepatitis B virus infection eligible for hepatitis B antiviral treatment worldwide: a systematic review and meta-analysis.全球范围内符合乙型肝炎抗病毒治疗条件的慢性乙型肝炎病毒感染者比例估计:一项系统评价和荟萃分析。
Lancet Gastroenterol Hepatol. 2021 Feb;6(2):106-119. doi: 10.1016/S2468-1253(20)30307-1. Epub 2020 Nov 14.
4
Electronic Health Informatics Data To Describe Clearance Dynamics of Hepatitis B Surface Antigen (HBsAg) and e Antigen (HBeAg) in Chronic Hepatitis B Virus Infection.电子健康信息数据描述慢性乙型肝炎病毒感染中乙型肝炎表面抗原 (HBsAg) 和 e 抗原 (HBeAg) 的清除动力学。
mBio. 2019 Jun 25;10(3):e00699-19. doi: 10.1128/mBio.00699-19.
5
Spontaneous loss of surface antigen among adults living with chronic hepatitis B virus infection: a systematic review and pooled meta-analyses.慢性乙型肝炎病毒感染者中表面抗原自发丢失:系统评价和汇总荟萃分析。
Lancet Gastroenterol Hepatol. 2019 Mar;4(3):227-238. doi: 10.1016/S2468-1253(18)30308-X. Epub 2019 Jan 22.
6
Factors Predicting HBsAg Seroclearance and Alanine Transaminase Elevation in HBeAg-Negative Hepatitis B Virus-Infected Patients with Persistently Normal Liver Function.预测HBeAg阴性、肝功能持续正常的乙型肝炎病毒感染患者HBsAg血清清除率及丙氨酸转氨酶升高的因素
PLoS One. 2016 Dec 9;11(12):e0166543. doi: 10.1371/journal.pone.0166543. eCollection 2016.
7
Role of serum quantitative hepatitis B surface antigen (HBsAg) in HBsAg carriers in a follow-up community study.一项社区随访研究中血清定量乙型肝炎表面抗原(HBsAg)在HBsAg携带者中的作用
Kaohsiung J Med Sci. 2015 Jul;31(7):386-7. doi: 10.1016/j.kjms.2015.04.003. Epub 2015 May 5.
8
Clinical importance of serum hepatitis B surface antigen quantification in the natural history of chronic hepatitis B infection.血清乙型肝炎表面抗原定量在慢性乙型肝炎感染自然史中的临床重要性。
Kaohsiung J Med Sci. 2015 Jul;31(7):384-5. doi: 10.1016/j.kjms.2015.04.004. Epub 2015 May 5.

本文引用的文献

1
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update.《亚太地区慢性乙型肝炎管理共识声明:2012年更新版》
Hepatol Int. 2012 Jun;6(3):531-61. doi: 10.1007/s12072-012-9365-4. Epub 2012 May 17.
2
Longitudinal change of HBsAg in HBeAg-negative patients with genotype B or C infection.HBsAg 在 B 型或 C 型基因型感染的 HBeAg 阴性患者中的纵向变化。
PLoS One. 2013;8(2):e55916. doi: 10.1371/journal.pone.0055916. Epub 2013 Feb 20.
3
Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads.血清乙型肝炎表面抗原水平有助于预测低乙型肝炎病毒载量患者的疾病进展。
Hepatology. 2013 Feb;57(2):441-50. doi: 10.1002/hep.26041. Epub 2012 Dec 6.
4
EASL clinical practice guidelines: Management of chronic hepatitis B virus infection.欧洲肝脏研究学会临床实践指南:慢性乙型肝炎病毒感染的管理
J Hepatol. 2012 Jul;57(1):167-85. doi: 10.1016/j.jhep.2012.02.010. Epub 2012 Mar 20.
5
Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load.乙肝表面抗原阴性低病毒载量患者自发表面抗原消失的决定因素。
Hepatology. 2012 Jan;55(1):68-76. doi: 10.1002/hep.24615.
6
Hepatitis B surface antigen monitoring and management of chronic hepatitis B.乙型肝炎表面抗原监测和慢性乙型肝炎的管理。
J Viral Hepat. 2011 Jul;18(7):449-57. doi: 10.1111/j.1365-2893.2011.01465.x. Epub 2011 May 23.
7
Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconverters.血清乙型肝炎表面抗原水平可预测乙型肝炎 e 抗原血清学转换者的表面抗原丢失。
Gastroenterology. 2011 Aug;141(2):517-25, 525.e1-2. doi: 10.1053/j.gastro.2011.04.046. Epub 2011 Apr 28.
8
Natural history of chronic hepatitis B REVEALed.慢性乙型肝炎的自然史被揭示。
J Gastroenterol Hepatol. 2011 Apr;26(4):628-38. doi: 10.1111/j.1440-1746.2011.06695.x.
9
Quantification of hepatitis B surface antigen: a new concept for the management of chronic hepatitis B.乙型肝炎表面抗原定量检测:慢性乙型肝炎管理的新概念。
Liver Int. 2011 Jan;31 Suppl 1:122-8. doi: 10.1111/j.1478-3231.2010.02390.x.
10
Community-based screening for hepatocellular carcinoma in elderly residents in a hepatitis B- and C-endemic area.在乙型肝炎和丙型肝炎流行地区,对老年居民进行基于社区的肝细胞癌筛查。
J Gastroenterol Hepatol. 2011 Jan;26(1):129-34. doi: 10.1111/j.1440-1746.2010.06476.x.